Výsledky vyhledávání - "Jeremy Odillard"

Abstract 1654: Mouse models of hepatocellular carcinoma: A comprehensive and functional preclinical platform for immunotherapy research

Autor: Olivier Duchamp, Gael Krysa, Loic Morgand, Hugo Quillery, Robin Artus, Maxime Ramelet, Jeremy Odillard, Peggy Provent, Sylvie Maubant, Caroline Mignard, Fabrice Viviani, Samira Benhamouche-Trouillet

Publikováno v: Cancer Research. 82:1654-1654

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death and accounts for over 80% of primary liver cancer worldwide. Early stage HCC can be treated by local ablation, surgical resection or liver transplantation. Systemic ph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bad312b075e21f4432042a8ddb4bddf1
https://doi.org/10.1158/1538-7445.am2022-1654

Zobrazit plný text záznamu

Abstract 5638: Liver preclinical models - acute, chronic and cancer models

Autor: Peggy Provent, Laure Levenez, Hugo Quillery, Edwige Nicodeme, Maxime Ramelet, Samira Benhamouche-Trouillet, Loïc Morgand, Gael Krysa, Anne Lazzari, Robin Artus, Adelaide Ferment, Valerie Boullay, ‖ Anne-Bénédict Boullay, Olivier Duchamp, Jeremy Odillard

Publikováno v: Cancer Research. 80:5638-5638

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death and accounts for >80% of primary liver cancer worldwide. Early stage HCC can be treated by local ablation, surgical resection or liver transplantation. Systemic pharma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6ccfbe25e892f310be76ba7aa89cbf45
https://doi.org/10.1158/1538-7445.am2020-5638

Zobrazit plný text záznamu

Abstract 3228: Immune checkpoint blockade and autoimmune diseases: Development of a mouse model of colitis induced by anti-CTLA-4

Autor: Olivier Duchamp, Valerie Boullay, Ingrid Jacquet, Anne-Benedicte Boullay, Florence Blandel, Jean-Jacques Tousaint, Edwige Nicodeme, Jeremy Odillard, Yannick Saintillan, Robin Artus, Fabrice Viviani, Gael Krysa, Laure Levenez

Publikováno v: Cancer Research. 79:3228-3228

Immunotherapies prime or activate patient’s immune system to fight disease and has recently been a source of registered and promising new cancer treatments with major beneficial clinical outcomes in several cancers. However, by increasing the activ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cd07bd9619a2ab15bf1fe271b10a6ffb
https://doi.org/10.1158/1538-7445.am2019-3228

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání